Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Myeloid Leukaemias (AML)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT05982756
What this trial is testing

Bortezomib Combined With DAG Regimen in the Treatment of Refractory/Relapsed AML

Who this might be right for
BortezomibAcute Myeloid Leukemia
Zhongnan Hospital 40
Early research (Phase 1)UnknownNCT05467254
What this trial is testing

Evaluate the Safety and Efficacy of CLL1+CD33 CAR-T in Patients With R/R AML

Who this might be right for
AML
Zhejiang University 20
Testing effectiveness (Phase 2)UnknownNCT04906031
What this trial is testing

Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid LeukemiaMyeloid Malignancy+3 more
First Affiliated Hospital of Jinan University 5
Testing effectiveness (Phase 2)Study completedNCT02789254
What this trial is testing

FLYSYN in MRD Positive AML

Who this might be right for
Acute Myeloid Leukemia
Synimmune GmbH 31
Early research (Phase 1)Ended earlyNCT01455025
What this trial is testing

Study in Plerixafor and Granulocyte-colony Stimulating Factor Patients With Relapse Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
French Innovative Leukemia Organisation 11
Not applicableEnded earlyNCT00967525
What this trial is testing

Intraosseous Infusion of Unrelated Cord Blood Grafts

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+1 more
Emory University 5
Early research (Phase 1)Study completedNCT00470197
What this trial is testing

Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+13 more
National Cancer Institute (NCI) 35
Not applicableUnknownNCT04460950
What this trial is testing

Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms

Who this might be right for
Acute Myeloid LeukemiaFamilial Acute Myeloid LeukemiaMyelodysplastic Syndromes
Gruppo Italiano Malattie EMatologiche dell'Adulto 237
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07726576
What this trial is testing

Venetoclax in Association With 3+7 and Midostaurin in FLT3-mutated Acute Myeloid Leukemia

Who this might be right for
Leukemia, Myeloid, Acute
University Hospital, Bordeaux 41
Testing effectiveness (Phase 2)Looking for participantsNCT04068597
What this trial is testing

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Who this might be right for
Haematological MalignancyAcute Myeloid LeukemiaNon Hodgkin Lymphoma+3 more
CellCentric Ltd. 250
Testing effectiveness (Phase 2)Ended earlyNCT01343368
What this trial is testing

Preservation of Ovarian Function After Hematopoietic Cell Transplant

Who this might be right for
Multiple MyelomaNon-Hodgkin LymphomaHodgkin Disease+2 more
Masonic Cancer Center, University of Minnesota 19
Not applicableStudy completedNCT06030089
What this trial is testing

Plasma Dosage of Venetoclax in the Fup of AML Patients Treated With Aza + Ven

Who this might be right for
Acute Myeloid Leukemia
Centre Hospitalier Universitaire de Nice 20
Early research (Phase 1)Study completedNCT01399840
What this trial is testing

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeChronic Lymphocytic Leukemia+1 more
Pfizer 33
Early research (Phase 1)Study completedNCT00588991
What this trial is testing

Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders

Who this might be right for
Adult Acute Megakaryoblastic LeukemiaAdult Acute Monoblastic LeukemiaAdult Acute Monocytic Leukemia+20 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Looking for participantsNCT04905810
What this trial is testing

Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure

Who this might be right for
Acute Myeloid LeukemiaRecurrent Acute Myeloid Leukemia
Brian Jonas 20
Testing effectiveness (Phase 2)Study completedNCT00778375
What this trial is testing

Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
M.D. Anderson Cancer Center 122
Not applicableStudy completedNCT00281801
What this trial is testing

Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Case Comprehensive Cancer Center 168
Post-approval studies (Phase 4)Study completedNCT07773909
What this trial is testing

Venetoclax With Hypomethylating Agents in Newly Diagnosed AML Unfit for Intensive Chemotherapy

Who this might be right for
Acute Myeloid Leukemia
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 24
Post-approval studies (Phase 4)Study completedNCT00488709
What this trial is testing

Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
PETHEMA Foundation 47
Testing effectiveness (Phase 2)Study completedNCT00003619
What this trial is testing

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+1 more
Drexel University College of Medicine
Next Page